Arthneeti

Hikal — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of Hikal holds 68.85% of the company. At a market capitalisation of ₹2.72k cr, that holding is worth ₹1.87k cr.

Promoter stake

68.85%

Value of holding

₹1.87k cr

Market cap

₹2.72k cr

Stake change

+0.08%

Promoter stake, quarter by quarter

QuarterHoldingStake %Pledged
Q2-2021
68.77%—
Q3-2021
68.77%—
Q4-2021
68.77%—
Q1-2022
68.77%—
Q2-2022
68.77%—
Q3-2022
68.77%—
Q4-2022
68.83%—
Q1-2023
68.85%—
Q2-2023
68.85%—
Q3-2023
68.85%—
Q4-2023
68.85%—
Q1-2024
68.85%—
Q2-2024
68.85%—
Q3-2024
68.85%—
Q4-2024
68.85%—
Q1-2025
68.85%—
Q2-2025
68.85%—
Q3-2025
68.85%—
Q4-2025
68.85%—
Q1-2026
68.85%—
Q2-2026
68.85%—
Q3-2026
68.85%—

Promoter holdings in Pharmaceuticals & Biotechnology

What this figure is, and is not

The value shown is Hikal's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.